Massalou et al.31 observed that both KRAS and BRAF mutation were associated with mucinous differentiation but not clearly related to prognosis, while Jones et al.32 identified a subgroup of BRAF mutations outside codon 600 in patients with metastatic colorectal cancer linked with favorable prognosis. Here, KRAS is linked to metastatic colorectal cancer.